Avoro Capital Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-496,983
Closed -$89.4M 55
2017
Q3
$89.4M Sell
496,983
-309,767
-38% -$43.2M 6.93% 3
2017
Q2
$83.6M Buy
+806,750
New +$65.8M 10.56% 2

Avoro Capital Advisors's KITE Position: Q4 2017 in Review

Avoro Capital Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 496,983 shares — an estimated $89.4M sold.

Avoro Capital Advisors first reported a position in KITE in Q2 2017 and held it in 2 quarters. The position peaked at $89.4M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Avoro Capital Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Avoro Capital Advisors sold 496,983 Kite Pharma, Inc. shares in Q4 2017, an estimated $89.4M.
  • Avoro Capital Advisors first reported a position in Kite Pharma, Inc. in Q2 2017 and held it in 2 quarters.
  • Avoro Capital Advisors's Kite Pharma, Inc. position peaked at $89.4M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Avoro Capital Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.